Efficacy, long‐term safety, and impact on quality of life of elobixibat in more severe constipation: Post hoc analyses of two phase 3 trials in Japan
Atsushi Nakajima(Yokohama City University), Michael Camilleri(CSIRO Manufacturing), Per‐Göran Gillberg(Uppsala University), Shinsuke Kurosu(EA Pharma (Japan)), Shinya Taniguchi(Konan University), Jan P. Mattsson(Novartis (Switzerland))
Cited by 33
Related Papers
Functional Gastroduodenal Disorders
|Gastroenterology|2006|2.4k
Intestinal barrier function in health and gastrointestinal disease
|Neurogastroenterology & Motility|2012|886
Laboratory characterisation of coal reservoir permeability for primary and enhanced coalbed methane recovery
|International Journal of Coal Geology|2009|477